Tinybots, founded in 2015 and headquartered in The Netherlands, operates at the intersection of Health Care and Robotics. Its flagship product, Tessa, is a social healthcare assistant designed to empower individuals with cognitive impairments—such as dementia, autism, and acquired brain injuries—to achieve greater autonomy in their daily routines.
By offering verbal guidance, Tessa enables users to become more self-reliant and prolongs their ability to live independently, effectively reducing their dependence on professional healthcare services. Tinybots addresses a critical societal issue: the rise in dementia cases coupled with a shortage in the healthcare workforce.
The company has demonstrated its potential by securing a €250.00K Convertible Note investment on 01 March 2018. As Tinybots looks to expand its impact, it presents an appealing opportunity for investors interested in innovative solutions within the healthcare sector.